Mounjaro®
Starting from £179.99/mo
Start journey Learn moreConstipation is one of the more common side effects people notice on semaglutide, because the medicine slows gastric emptying and bowel transit along with it. It usually settles within a few weeks, and there are practical steps that genuinely help — though if symptoms are severe or persist, your prescriber should know. Wegovy is a prescription-only medicine; a clinician decides whether it is suitable for you and guides you through managing any side effects that arise. The full picture of Wegovy side effects covers the broader list, but constipation deserves its own attention because the decisions you make around managing it interact directly with cost, consistency, and how long you stay on treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
That is the real decision most people on Wegovy face around constipation. Semaglutide slows the rate at which food moves through your gut (a feature, not a flaw, because the same mechanism reduces appetite) but the knock-on effect can be noticeably slower bowel transit, particularly in the first weeks at a new dose. The NHS patient information for semaglutide lists constipation among the common side effects and notes it tends to ease as your body adjusts.
Before spending money on anything, run a quick check you can do in under a minute: look at what you drank yesterday. Fluid intake is the single factor patients most often underestimate. Dehydration compounds the motility-slowing effect of semaglutide, and many people find that a deliberate push to around 2 litres of water across the day (not sugary drinks, not just coffee) produces a noticeable improvement within 48 hours. Fibre matters too, but adding fibre without adequate fluid can worsen things rather than help.
The decision framework here is: fluid and fibre first (cost: nothing), then gentle movement, then over-the-counter options if needed, then prescriber review. Skipping straight to supplements without addressing hydration wastes money and sometimes prolongs the problem. If you are already well-hydrated and still struggling after two or three weeks at a dose, that is the right moment to contact your clinical team rather than self-manage further.
UK private Wegovy treatment is priced per prescription period and varies between providers. Since Eli Lilly's list-price adjustment in autumn 2025, typical private market prices for tirzepatide have shifted noticeably, and the same competitive pressures are visible across semaglutide providers. For Wegovy specifically, reported private prices typically range in the region of £149–£375 per month depending on dose and provider, though these figures move and should be treated as market context rather than guarantees.
What those headline figures frequently exclude is worth stating plainly: many quoted prices cover the pen only. Consultation fees, prescription charges, delivery, and ongoing clinical review are often billed separately, which means the real monthly outlay can be meaningfully higher than the number shown in the ad. Understanding the full cost structure of Wegovy in the UK before committing matters, particularly if you are budgeting for the add-on costs of managing side effects over several months, and it is also worth checking whether your provider offers a Wegovy deal that bundles consultation and aftercare into a single transparent price.
On the side-effect cost side: most first-line constipation management is inexpensive. Increased fluid intake, a portion of oat bran or linseed added to meals, and short walks are free. If you need a short course of a gentle osmotic laxative from a pharmacy, that typically costs a few pounds. The more significant cost risk is discontinuing treatment prematurely because unmanaged constipation made it feel unsustainable, which wastes whatever you have already spent and interrupts the clinical progress you have made.
At nume, one price covers the consultation, the prescription, the medicine, and delivery, nothing is billed separately. We are not the cheapest option on the market, and that is a deliberate choice. What the price buys is seven-day aftercare access, meaning that if constipation becomes persistent, uncomfortable, or you are unsure whether it is something more serious, you can reach your prescriber without booking a separate appointment or paying another fee. The way we work is built around that kind of continuity rather than a one-and-done pen-plus-prescription model.
That access matters practically for a side effect like constipation, which can escalate into something requiring clinical guidance, particularly if it coincides with severe nausea, signs of dehydration, or cramping that suggests more than routine gut slowdown. Our clinical team can also advise on practical questions such as how much sterile water to use when reconstituting 5mg semaglutide, so you are never left to work through the details alone. The NHS England guidance on weight-management injections specifically advises patients to contact their healthcare team if side effects become difficult to manage, rather than adjusting treatment independently.
If you want to understand what is included in detail before starting, the FAQs answer common questions about aftercare and the clinical review process. For a broader look at the semaglutide side-effect profile, including how nausea tends to interact with constipation, the nausea guide is worth reading alongside this one.
Discount codes for prescription medicines are a red flag, not a saving. The MHRA has repeatedly warned that sellers offering GLP-1 pens at prices far below market rates, or without requiring a proper clinical assessment, are a source of counterfeit or unlicensed product. Report suspect sellers at the MHRA's Yellow Card scheme. Genuine savings on a prescription medicine come from clinical efficiency (getting the dose right early, managing side effects so you stay on treatment, and having prescriber access when something changes) not from stripping out the clinical layer. You can verify any online pharmacy's registration at the GPhC register; nume's GPhC premises number is 9012878.
Constipation that is poorly managed increases the chance of dose delays, interruptions, or stopping treatment altogether. Those outcomes cost more in time and money than an osmotic laxative ever would. If you are weighing up providers partly on price, the relevant question is not who charges least per pen, but who keeps you clinically supported across the months it takes to see results, and good support includes guidance on how to deal with nausea from semaglutide alongside constipation, since the two side effects often overlap. The Wegovy strengths and pricing page sets out how the dose journey maps to cost over time. Start your free consultation and a GPhC-registered prescriber will review your suitability and talk through managing any side effects from day one.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.